Forman Mark S
Transaction: 03/04/2026
SELL
Change
-6,000
Price
$14.00
Filing
03/04/2026
Type
SELL
Ventyx Biosciences, Inc.
VTYX • Biotechnology
$14.00
— 0.00 (0.00%)
Current price
EarningsLatest report: Sep 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$998.26M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 17.97Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 6, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$14.00
Change0.00%
Shares Out71.30M
Market Cap$998.26M
Enterprise Value$805.62M
52W Range0.78 - 25.00
Beta1.27
P/E-9.36
P/B5.22
P/FCF-11.36
EV/EBITDA-7.09
EV/FCF-9.17
Price$14.00
Change0.00%
Shares Out71.30M
Market Cap$998.26M
Enterprise Value$805.62M
52W Range0.78 - 25.00
Beta1.27
P/E-9.36
P/B5.22
P/FCF-11.36
EV/EBITDA-7.09
EV/FCF-9.17
Earnings Yield-10.68%
FCF Yield-8.80%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio17.97
Quick Ratio17.97
Target$26.78
Target Upside91.29%
Target Median$14.00
Target Range14.00 - 60.00
Volume5.40M
Avg Volume3.81M
EPS Surprise0.13
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 17.97Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
65/100
Neutral
Bullish
4
Hold
9
Bearish
0
Price Target
2026-06-06
Low
$14.00
Mean
$14.00
Median
$14.00
High
$14.00
Insider Transactions
Recent executive and insider activity
⚠ 9 high-volume insider sells detected
Forman Mark S
Transaction: 03/04/2026
SELL
Change
-350,000
Price
$1.95
Filing
03/04/2026
Type
SELL
Mohan Raju
Transaction: 03/04/2026
SELL
Change
-23,688
Price
Not reported
Filing
03/04/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Forman Mark S | SELL | -6,000 | $14.00 | 03/04/2026 | 03/04/2026 |
| Forman Mark S | SELL | -350,000 | $1.95 | 03/04/2026 | 03/04/2026 |
| Mohan Raju | SELL | -23,688 | Not reported | 03/04/2026 | 03/04/2026 |
| Mohan Raju | SELL | -466,672 | $14.48 | 03/04/2026 | 03/04/2026 |
| Mohan Raju | SELL | -2,372,863 | $14.00 | 03/04/2026 | 03/04/2026 |
| Nuss John | SELL | -9,063 | Not reported | 03/04/2026 | 03/04/2026 |
| Nuss John | SELL | -489,481 | $14.00 | 03/04/2026 | 03/04/2026 |
| Nuss John | SELL | -125,000 | $2.49 | 03/04/2026 | 03/04/2026 |
| GUJRATHI SHEILA | SELL | -15,937 | $34.83 | 03/04/2026 | 03/04/2026 |
| GUJRATHI SHEILA | SELL | -130,000 | $14.00 | 03/04/2026 | 03/04/2026 |
| HULME ALLISON | SELL | -20,000 | $1.97 | 03/04/2026 | 03/04/2026 |
| Cadoret-Manier Onaiza | SELL | -40,000 | $2.25 | 03/04/2026 | 03/04/2026 |
| Moore Matthew Richard | SELL | -320,000 | $4.98 | 03/04/2026 | 03/04/2026 |
| White William Richard | SELL | -21,825 | $16.54 | 03/04/2026 | 03/04/2026 |
| Subramaniam Somu | SELL | -3,337,495 | $14.00 | 03/04/2026 | 03/04/2026 |
| Subramaniam Somu | SELL | -21,825 | $16.54 | 03/04/2026 | 03/04/2026 |
| Gonzales Roy | SELL | -35,000 | $2.49 | 03/04/2026 | 03/04/2026 |
| Gonzales Roy | SELL | -5,313 | $14.00 | 03/04/2026 | 03/04/2026 |
| Subramaniam Somu | SELL | -694,718 | Not reported | 02/27/2026 | 03/03/2026 |
| Nuss John | SELL | -12,675 | $7.72 | 12/18/2025 | 12/19/2025 |